Eye disease treatment study using medical records
Part of Eyes & vision clinical trials.
This study uses a computer system to look at medical records of people who have had a certain type of eye injection. It aims to improve how information about eye treatments is shared and understood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received a specific type of eye injection (OPS code 5-156.9) where medicine is injected into the back part of your eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to keep the eye open during injections for conditions like wet macular degeneration. It tests a new method using a cotton-tipped applicator instead of a speculum to see if it is less painful and just as safe.
This trial tests whether specially trained nurses can safely give eye injections instead of doctors. It may make treatment quicker and easier for people who need regular injections for eye conditions.
This study tests whether a coordinated team approach can help patients stick with regular eye injections for conditions like age-related macular degeneration and diabetic eye disease. Researchers want to see if extra support and planning improve how often patients complete their recommended treatments.
This is an early-stage safety study testing a new medicine injected directly into the eye to treat diabetic retinopathy (damage to blood vessels in the retina caused by diabetes). The study checks if the medicine is safe and how the body processes it.
This study looks at how repeated eye injections of a drug called bevacizumab affect chemicals in your blood that relate to heart health and inflammation. Researchers want to understand if these eye injections might impact your cardiovascular risk.
This trial looks at how often inflammatory flare-ups happen in patients with a type of eye inflammation called posterior uveitis. It focuses on people who have been treated with a fluocinolone acetonide implant, a tiny device placed in the eye that releases medicine over time, and aims to understand how well it controls inflammation.
Hear when a new Intravitreal Injections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.